After PR, the PSQI score decreased from 9.41 ؎ 4.33 to 7.82 ؎ 3.90 (P < .001). The number of subjects with a PSQI score > 5 also decreased (85.3-64.7%, P ؍ .006). There were significant improvements in HRQOL (SGRQ, P ؍ .003), exercise capacity (peak oxygen uptake, P < .001; and work rate, P < .001), dyspnea score (P < .001), and respiratory muscle strength (inspiratory muscle strength, P ؍ .005; and expiratory muscle strength, P ؍ .004) after PR. There were no significant changes in pulmonary function test results (FEV 1 , P ؍ .77; FVC, P ؍ .90; FEV 1 /FVC, P ؍ .90). CONCLUSIONS: PR results in significant improvement in sleep quality, along with concurrent improvements in HRQOL and exercise capacity. PR is an effective nonpharmacologic treatment to improve sleep quality in patients with COPD and should be part of their clinical management.